Quantcast

Latest European Society for Medical Oncology Stories

2014-09-22 04:21:55

LUGANO, Switzerland, September 22, 2014 /PRNewswire/ -- Helsinn Group, a company focused on building quality cancer care, today announces that it is supporting an independent educational satellite symposium on Delivering Chemotherapy With Confidence: New Strategies to Minimize Treatment-Induced Nausea and Vomiting at the 38th European Society for Medical Oncology (ESMO) Congress in Madrid, Spain, in 2014. Helsinn has awarded a grant to prIME oncology, a global...

2014-09-17 04:20:02

Tokyo, Sept 17, 2014 - (JCN Newswire) - Eisai Co., Ltd. announced today that a series of abstracts highlighting the latest clinical data on Halaven(R) (generic name: eribulin mesylate; non-taxane microtubule dynamics inhibitor, "Halaven") and lenvatinib mesylate (generic name; selective inhibitor of receptor tyrosine kinases (RTKs) with a novel binding mode, "lenvatinib") will be presented during the 39th European Society for Medical Oncology (ESMO) Congress...

2014-08-22 04:21:25

LUGANO, Switzerland, August 22, 2014 /PRNewswire/ -- The European Society for Medical Oncology (ESMO), the leading pan-European organisation representing medical oncologists, announced the names of outstanding individuals receiving the Society's esteemed annual awards, to be presented during the ESMO 2014 Congress, on 26 September, in Madrid. Carsten Bokemeyer will receive the ESMO Award...

2014-07-25 08:24:56

LUGANO, Switzerland, July 25, 2014 /PRNewswire/ -- The European Society for Medical Oncology (ESMO) has expressed concern that the proposed EU General Data Protection Regulation could make cancer research impossible and add a significant burden to cancer patients and doctors. (Logo: http://photos.prnewswire.com/prnh/20131128/654773 ) The proposed wording -'explicit and specific patient consent' - implies that researchers would have to approach patients and ask...

2014-06-30 13:06:13

European Society for Medical Oncology ESMO 16 World GI Congress on Gastrointestinal Cancer The new combination agent TAS-102 is able to improve overall survival compared to placebo in patients whose metastatic colorectal cancer is refractory to standard therapies, researchers said at the ESMO 16th World Congress on Gastrointestinal Cancer in Barcelona. "Around 50% of patients with colorectal cancer develop metastases but eventually many of them do not respond to standard therapies,"...

2014-06-30 12:40:20

European Society for Medical Oncology ESMO 16 World GI Congress on Gastrointestinal Cancer For patients with KRAS wild-type untreated colorectal cancer, adding cetuximab or bevacizumab to combination chemotherapy offers equivalent survival, researchers said at the ESMO 16th World Congress on Gastrointestinal Cancer in Barcelona. "The CALGB/SWOG 80405 trial was designed and formulated in 2005, and the rationale was simple: we had new drugs --bevacizumab and cetuximab-- and the study...

2014-06-16 04:21:36

LUGANO, Switzerland, June 16, 2014 /PRNewswire/ -- ESMO welcomes the adoption of the Clinical Trials Regulation by the EU The European Society for Medical Oncology (ESMO) has welcomed the adoption of the Clinical Trials Regulation [http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=uriserv:OJ.L_.2014.158.01.0001.01.ENG ] by the EU, entering into force today. The new framework acknowledges the importance of using data stored for a clinical trial beyond the end of...

2014-05-30 16:23:41

NEW YORK, May 30, 2014 /PRNewswire/ -- MedPage Today, a property of Everyday Health, Inc. (NYSE: EVDY), announces the launch of "Video Conference Reporter," to provide recorded real-time video coverage of major oncology research presented at leading scientific sessions worldwide. http://photos.prnewswire.com/prnvar/20101112/NY00568LOGO "Our partnerships with key professional medical organizations are one of the cornerstones of MedPage Today, and what sets us apart from other news...

2014-05-20 23:17:41

Elite cancer care specialists in Turkey are providing the latest technology and the most innovative, affordable therapies to increase the chances of a cure. Surgeons, radiologists, pathologists, radiation oncologists, and cancer care specialists at VisitandCare.com are working together to implement advanced treatment options to foreign cancer patients. Los Angeles, CA (PRWEB) May 20, 2014 A close collaboration between oncologists in Turkey and expert scientists is generating...

2014-01-30 23:22:47

The Advanced Practitioner Society for Hematology and Oncology (APSHO) launches at the First JADPRO Live: Transforming Oncology Practice conference. St. Petersburg, FL (PRWEB) January 30, 2014 Harborside Press announces the launch of the Advanced Practitioner Society for Hematology and Oncology (APSHO), a new organization focused on meeting the unique educational and professional needs of the advanced practitioner in hematology and oncology. The formation of the Society was announced on...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related